Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment

NACompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 10, 2017

Study Completion Date

August 10, 2017

Conditions
HIVOpiate Dependence
Interventions
BEHAVIORAL

Abstinence-reinforcing contingency management intervention

The contingency management intervention consists of participants receiving vouchers exchangeable for goods and services contingent on achieving abstinence. When participants are abstinent (urine is free of cocaine, oxycodone and opiates), they will receive a voucher. If participants are not abstinent (cocaine or oxycodone or opiates are in the urine), they will not receive a voucher. The value of vouchers increases with continued evidence of abstinence. When participants have urines with opiates or cocaine, the value of the voucher is reset. The vouchers are part of the intervention, they are not participant compensation.

BEHAVIORAL

Performance Feedback intervention

Participants will receive performance feedback about their drug use. The research team will provide informational slips of paper indicating results of urine tests and will congratulate participants when urines are drug-free or encourage participants to stop using cocaine and/or opiates when urines are not drug-free.

Trial Locations (3)

10451

Montefiore's Community Clinics (Montefiore Medical Group), The Bronx

10461

Albert Einstein College of Medicine Division of Substance Abuse clinics, The Bronx

10467

Montefiore Infectious Disease Clinic, The Bronx

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Albert Einstein College of Medicine

OTHER

NCT01376570 - Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment | Biotech Hunter | Biotech Hunter